期刊文献+

2008-2011年浙江省水痘疫情流行特征分析 被引量:9

Epidemiological characteristics of Varicella in Zhejiang Province in 2008~2011
下载PDF
导出
摘要 结果 分析浙江省水痘疫情发生情况,为开展相应的预防控制工作提供科学依据.方法 对2008-2010年浙江省报告的水痘病例及水痘暴发疫情用描述流行病学方法进行分析.结果 2008-2011年浙江省共报告水痘71406例,死亡2例,年平均发病率34.33/10万.丽水市发病率最高,达64.65/10万,温州市报告病例数占30.59%; 5~6月份和11~12月份是全年发病高峰;14岁以下人群占病例报告总数的77.40%.2008-2011年全省共报告水痘事件98起,其中97.95%发生在学校.结论 浙江省水痘疫情较严重,应进一步加强有关方面的宣教工作,落实学校卫生工作相关措施,开展水痘疫苗常规接种的推广和应急接种,确保水痘疫情的有效控制. Objective The present study was conducted to investigate the epidemic situation of varicella in Zhejiang Province for providing a scientific basis for the formulation of strategies for its control and prevention. Methods The methods of descriptive epidemiology were used to analyze the surveillance data from National Notifiable Diseases Reporting System(NNDRS) and Emergent Public Health Event Information Management System(EPHEIMS) on varicella form 2008 to 2011 in Zhejiang Province. Results A total of 71406 varicella and lcases died, the incidence rate was 34.33 per 100000 population.. The incidence rate in Lishui was 64.65 per 100000 population, which was the highest area, 30.59% cases were reported in Wenzhou; there were two obvious seasonal peak incidence in May to June and November to December; 77.40% cases were under 14 years of age.91 Varicella outbreaks were reported, 97.95% of which occurred in schools. Conclusion Varicella prevalence was existing in Zhejiang Province, health education, school health management and Varicella-Zoster vaccine immunization should be strengthened for the control and prevention of varicella.
出处 《中国卫生产业》 2013年第31期40-42,共3页 China Health Industry
关键词 水痘 流行特征 Varicella Epidemiological characteristics
  • 相关文献

参考文献4

二级参考文献39

  • 1Asano Y. Varicella vaccine:The Japanese experience [J] J Infect Dis, 1996,174(suppl 3):s310-313.
  • 2Takahashi M . Prevention of virus-related neurological deseases by vaccines. Vaccine 1997,15(1):61-64.
  • 3Beutels P. et al. Costs and benefits of routine varicella vaccination in German children. J Infect Dis 1996,174(supple 3):s335-s341.
  • 4Lee BW.Review of varicella zoster seroepidemiology in India and South-east Asia[J].Trop Med Intern Health,1998,3(11):886-890.
  • 5Takahashi M,Otsuka T,Okuno Y,et al.Live vaccine used to prevent the spread of varicella in children in hospital[J].Lancet,1974,2(7892):1288-1290.
  • 6White CJ.Varicella-zoster virus vaccine[J].Clin Infect Dis,1997,24(5):753-763.
  • 7Weibel RE,Neff BJ,Kuter BJ,et al.Live attenuated varicella virus vaccine:efficacy trial in healthy children[J].N Engl J Med,1984,310(22):1409-1415.
  • 8Preblud SR.Varicella:complications and costs[J].Pediatrics,1986,78(4Pt2):S728-S735.
  • 9Muench R,Nassim C,Niku S,et al.Seroepidemiology of varicella[J].J Infect Dis,1986,153(1):153-155.
  • 10Thiry N,Beutels P,Shkedy Z,et al.The seroepidemiology of primary varicella-zoster virus infection in Flanders(Belgium)[J].Eur J Pediatr,2002,161(11):588-593.

共引文献99

同被引文献58

引证文献9

二级引证文献115

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部